These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The fungal cell wall as a drug target. Georgopapadakou NH; Tkacz JS Trends Microbiol; 1995 Mar; 3(3):98-104. PubMed ID: 7773595 [TBL] [Abstract][Full Text] [Related]
4. Recent progress in the chemotherapy of human fungal diseases. Emphasis on 1,3-β-glucan synthase and chitin synthase inhibitors. Basha A; Basha F; Ali SK; Hanson PR; Mitscher LA; Oakley BR Curr Med Chem; 2013; 20(38):4859-87. PubMed ID: 24295405 [TBL] [Abstract][Full Text] [Related]
5. Chitin synthase inhibitors as antifungal agents. Chaudhary PM; Tupe SG; Deshpande MV Mini Rev Med Chem; 2013 Feb; 13(2):222-36. PubMed ID: 22512590 [TBL] [Abstract][Full Text] [Related]
6. Mode of action of clinically important antifungal drugs. Kerridge D Adv Microb Physiol; 1986; 27():1-72. PubMed ID: 3532715 [No Abstract] [Full Text] [Related]
7. On the mode of action of antimycotics, especially of clotrimazole (Canesten), on the ultrastructural level of human pathogenic fungi. Voigt WH Scand J Infect Dis Suppl; 1978; (16):51-8. PubMed ID: 285460 [No Abstract] [Full Text] [Related]
8. Exploitation of the direct cell damaging action of antifungal azoles. Beggs WH; Hughes CE Diagn Microbiol Infect Dis; 1987 Jan; 6(1):1-3. PubMed ID: 3802743 [No Abstract] [Full Text] [Related]
9. Iminosugars as glycosyltransferase inhibitors: synthesis of polyhydroxypyrrolidines and their evaluation on chitin synthase activity. Gautier-Lefebvre I; Behr JB; Guillerm G; Muzard M Eur J Med Chem; 2005 Dec; 40(12):1255-61. PubMed ID: 16095761 [TBL] [Abstract][Full Text] [Related]
10. Neopolyoxins A, B, and C: new inhibitors of fungal cell wall chitin synthetase. Uramoto M; Kobinata K; Isono K; Jenkins EE; McCloskey JA; Higashijima T; Miyazawa T Nucleic Acids Symp Ser; 1980; (8):s69-71. PubMed ID: 6454887 [No Abstract] [Full Text] [Related]
11. Sertaconazole: updated review of a topical antifungal agent. Carrillo-Muñoz AJ; Giusiano G; Ezkurra PA; Quindós G Expert Rev Anti Infect Ther; 2005 Jun; 3(3):333-42. PubMed ID: 15954850 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of chitin synthase 2 and antifungal activity of lignans from the stem bark of Lindera erythrocarpa. Hwang EI; Lee YM; Lee SM; Yeo WH; Moon JS; Kang TH; Park KD; Kim SU Planta Med; 2007 Jun; 73(7):679-82. PubMed ID: 17538872 [TBL] [Abstract][Full Text] [Related]
13. Fungal cell wall: An underexploited target for antifungal therapies. Ibe C; Munro CA PLoS Pathog; 2021 Apr; 17(4):e1009470. PubMed ID: 33886695 [No Abstract] [Full Text] [Related]
14. Asperfuran, a novel antifungal metabolite from Aspergillus oryzae. Pfefferle W; Anke H; Bross M; Steffan B; Vianden R; Steglich W J Antibiot (Tokyo); 1990 Jun; 43(6):648-54. PubMed ID: 2143181 [TBL] [Abstract][Full Text] [Related]
15. [Structure of fungi and the action mechanism of antifungal agents]. Nishiyama Y Jpn J Antibiot; 2002 Dec; 55(6):902-6. PubMed ID: 12664930 [No Abstract] [Full Text] [Related]
16. [Action of sulconazole on Candida and dermatophyte antigens]. Hearn VM Ann Dermatol Venereol; 1989; 116 Suppl 1():13-5. PubMed ID: 2688525 [No Abstract] [Full Text] [Related]
17. The structure and synthesis of the fungal cell wall. Bowman SM; Free SJ Bioessays; 2006 Aug; 28(8):799-808. PubMed ID: 16927300 [TBL] [Abstract][Full Text] [Related]
18. [Pharmacokinetics of imidazole-antimycotics (author's transl)]. Plempel M Mykosen; 1980 Jan; 23(1):16-27. PubMed ID: 7383054 [No Abstract] [Full Text] [Related]